Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06958003

Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime

The purpose of this study is to investigate the use of 3-5 minutes air therapy for the prevention and treatment of diaper dermatitis in infants 30 weeks and older receiving care in the neonatal intensive care unit (NICU).

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

30 week–1 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Good Samaritan Hospital

Cincinnati, Ohio, 45220, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Receiving care at Good Samaritan Hospital NICU
  • At least 30 weeks gestation at birth and corrected or older or corrected gestation
  • Birth to 1 year old
  • Stable vital signs (temperature, pulse, blood pressure, and oxygen saturation)

Exclusion criteria

  • Parent/legal guardian unable or unavailable to consent to involvement in the study
  • Congenital malformation impacting diaper area or spine

Treatment and study plan

Air Therapy

Other

3-5 minutes of air therapy in addition to routine diaper care

Primary outcomes

  1. Occurrence of diaper dermatitis

    Time frame: from admission to discharge from NICU, up to 6 months

    Whether infant is diagnosed with diaper dermatitis while in the NICU

Sponsors and collaborators

Lead sponsor

TriHealth Inc.

Other

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
May 6, 2025
Registry last updated
Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.